Global Leaders in Mobile ECG Connectivity
- 20 years of medical credibility licensing technologies to hospitals, physicians, remote patient monitoring platforms, research groups and commercial call centers
- Sold into > 20 countries, with the largest customer base located in the US
- Class II medical device clearances and device agnostic for collecting, viewing, recording, analyzing and storing of ECGs for management of patient and consumer health
- ECG solutions for both consumer (OTC) and medical (Rx) markets
- Owns all IP and source code
- Market expert contributor for reports in mâ€health, mobile cardiac monitoring and new advances in consumer health and wellness monitoring
Recent Highlights
CardioComm Solutions’ HeartCheck(TM) Device Enters Final FDA Review Phase Read More
- Completed a request for additional information from the US Food and Drug Administration (“FDA”) for the Company’s premarket notification 510(k), Class II medical device clearance application for the HeartCheck™ CardiBeat and GEMS™ Mobile Application.
- Company had submitted a letter of revocation of their supplementary information submission on December 26, 2018 in compliance with the FDA’s directive
CardioComm Solutions’ HeartCheck(TM) CardiBeat and Smart Phone App Enter Final Stage of FDA 510(k) Review Read More
- Market Release of HeartCheck(TM) CardiBeat and GEMS(TM) Mobile Application Set For Early 2019
- Completed its response to the USA Food and Drug Administration for
additional information following the Company’s filing of its premarket
notification 510(k)
- Class II medical device clearance application for the HeartCheck™ CardiBeat and GEMS™ Mobile Application
- HeartCheck™ CardiBeat is the second of several planned Bluetooth-enabled ECG recording devices to be marketed by the Company
Launched 12-Lead ECG Smart Wearable Garment Monitoring Solution Read More
- Announced joint partnership sales plans for the commercial launch of its newest software release designed to support an innovative and easy to use wireless, 12 lead ECG, vital signs, arrhythmia and ischemia monitoring wearable smart garment manufactured by Israel-based HealthWatch Technologies Ltd.
Products
The Project: Arrhythmia Screening and Medical Adherence
An Innovator in the Mobile ECG Industry
Company Accolades
FULL DISCLOSURE: CardioComm Solutions Inc. is an advertising client of AGORA Internet Relations Corp.